Cargando…
Editorial: Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872103/ https://www.ncbi.nlm.nih.gov/pubmed/36703780 http://dx.doi.org/10.3389/fonc.2022.1121120 |
_version_ | 1784877330666094592 |
---|---|
author | Pyo, Kyoung-Ho Rahman, S. M. Mazidur Boraschi, Diana |
author_facet | Pyo, Kyoung-Ho Rahman, S. M. Mazidur Boraschi, Diana |
author_sort | Pyo, Kyoung-Ho |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9872103 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98721032023-01-25 Editorial: Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control Pyo, Kyoung-Ho Rahman, S. M. Mazidur Boraschi, Diana Front Oncol Oncology Frontiers Media S.A. 2023-01-10 /pmc/articles/PMC9872103/ /pubmed/36703780 http://dx.doi.org/10.3389/fonc.2022.1121120 Text en Copyright © 2023 Pyo, Rahman and Boraschi https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Pyo, Kyoung-Ho Rahman, S. M. Mazidur Boraschi, Diana Editorial: Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control |
title | Editorial: Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control |
title_full | Editorial: Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control |
title_fullStr | Editorial: Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control |
title_full_unstemmed | Editorial: Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control |
title_short | Editorial: Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control |
title_sort | editorial: development of small molecule inhibitors and antibodies targeting axl for tumor therapy and infectious disease control |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872103/ https://www.ncbi.nlm.nih.gov/pubmed/36703780 http://dx.doi.org/10.3389/fonc.2022.1121120 |
work_keys_str_mv | AT pyokyoungho editorialdevelopmentofsmallmoleculeinhibitorsandantibodiestargetingaxlfortumortherapyandinfectiousdiseasecontrol AT rahmansmmazidur editorialdevelopmentofsmallmoleculeinhibitorsandantibodiestargetingaxlfortumortherapyandinfectiousdiseasecontrol AT boraschidiana editorialdevelopmentofsmallmoleculeinhibitorsandantibodiestargetingaxlfortumortherapyandinfectiousdiseasecontrol |